Trial Profile
Clinical research of azilsartan in hypertention patients with metabolic diseases
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2013
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 03 Jul 2013 New trial record